## Understanding Cohort vs Case-Control Study Efficiency ### Why Option 1 is Correct (The Exception) **Key Point:** Case-control studies are MORE efficient for studying rare diseases, not cohort studies. Cohort studies are inefficient for rare outcomes because you must follow a large population for extended periods to observe few events. ### Comparison of Study Designs for Rare Diseases | Feature | Cohort Study | Case-Control Study | |---------|--------------|--------------------| | Efficiency for rare diseases | Poor (need huge n) | Excellent (select cases directly) | | Time to completion | Long (prospective) | Short (retrospective) | | Cost for rare outcomes | High | Low | | Temporal sequence | Clear | Inferred | ### Why the Other Options are Correct **Option 0 (Temporal relationship):** Cohort studies follow exposed and unexposed groups forward in time, establishing clear temporal precedence — exposure occurs before outcome. **Option 2 (Incidence & RR):** Cohort studies directly measure incidence rates in exposed and unexposed groups, allowing calculation of relative risk (RR = Incidence~exposed~ / Incidence~unexposed~). Case-control studies cannot calculate true incidence or RR; they calculate odds ratio (OR) instead. **Option 3 (Multiple outcomes):** A single cohort can be followed for many different health outcomes from one or more exposures — a major advantage for hypothesis generation and efficiency. ### High-Yield Mnemonic **"RARE = Case-Control; COMMON = Cohort"** - **R**are disease → **A**llocate cases → **R**etrospective → **E**fficient - Cohort: good for common outcomes, poor for rare ones **Clinical Pearl:** In India, case-control studies of rare cancers (e.g., mesothelioma from asbestos exposure) are far more practical than recruiting a massive cohort and waiting years for disease development. [cite:Park 26e Ch 8]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.